BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2012
View Archived Issues
Novel products patented at Merck & Co.
Read More
New agents for hypertension divulged
Read More
HIV integrase inhibitors discovered by U.S. and Canadian team
Read More
Shionogi & Co. patents novel beta-secretase inhibitors
Read More
Glaucoma gene therapy protects retinal ganglion cells
Read More
Vertex provides additional data from VX-809/Kalydeco combination study
Read More
Marshall Edwards updates on phase I study of anticancer candidate
Read More
Modification of EarlyCDT-Lung significantly increases specificity and overall accuracy of the test
Read More
New cancer/testis antigen may be biomarker for renal cell carcinoma
Read More
Soricimed Biopharma clear to commence phase I trial of novel anticancer agent
Read More
Boehringer Ingelheim discloses novel FLAP inhibitors
Read More
Eurocine Vaccines reports on pneumococcal glycoconjugate vaccine
Read More
EMA committee issues opinion on orphan drug status for sickle cell disease therapy
Read More
Canadian study reveals novel blood biomarker for osteoarthritis
Read More
Research collaboration agreement set for stem cell and tissue repair research
Read More
First patients treated in corneal epithelial stem cell transplant study
Read More
Flexion's lead osteoarthritis product relieves pain in phase II trial
Read More
Preliminary phase III data show efficacy for CompleoTRT
Read More
Alnylam reports on phase IIb ALN-RSV01 trial
Read More
Celsion completes enrollment in pivotal HEAT study
Read More
City of Hope obtains grant to develop T-cell treatment targeting brain tumor cells
Read More
Chemokine CXCR4 receptor antagonist shows promise in resistant/refractory AML
Read More
FDA requires integrated safety analysis before continued studies of oral Proellex
Read More
Phase I RenaZorb study enrolls first patients
Read More
Omni Bio provides updated results from pilot study in type 1 diabetes
Read More
Alkermes announces development decision regarding ALKS-37
Read More
Actelion launches drug in Japan for Niemann-Pick type C disease
Read More